Table: Kidswell Bio -Q1 group results
Aug 13 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2026 Jun 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.27 1.72
(-26.2 pct) (+256.3 pct)
Operating 216 mln 184 mln
(+17.3 pct)
Recurring 203 mln 175 mln
(+16.0 pct)
Net 197 mln 157 mln
(+26.0 pct)
EPS 3.99 yen 3.31 yen
EPS Diluted 3.90 yen 3.26 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T